New research involving Irish scientists could lead to effective new treatments for the most common type of arthritis within the next five years.
Scientists based at NUI Galway are part of an EU-funded project – ADIPOA – that is investigating how stem cells from adult fat tissue may be used to activate the regeneration of cartilage. This could lead to new treatments for the condition, osteoarthritis (OA).
OA usually develops gradually over several years, and affects a number of different joints. It is characterised by a degeneration of cartilage in these joints and can be very painful.
Around 400,000 people in Ireland and 70 million in the EU are affected by the condition
According to the scientists, the phase one clinical trial has just finished and early results have so far been positive. Based on these findings, a new and effective treatment for OA could become a reality within the next few years.
“Until now there were just two possible outcomes for suffers of this progressive and debilitating disease – joint replacement surgery, in the case of advanced disease or, life-long pain management. From the clinical trials conducted so far, we have seen the first signs of finding a cure for this truly incapacitating disease which affects so many,” commented Prof Frank Barry, scientific director of the Regenerative Medicine Institute (REMEDI) at NUI Galway and a partner in the ADIPOA project.
He pointed out that using the patient’s own stem cells, the scientists were able to ‘treat their diseased joints and relieve their suffering and burden of pain’.
“While we are still in the early stages of clinical trials, the results so far are extremely positive, such that the use of stem cell therapy for osteoarthritis could become a reality for patients within the next five years,” he insisted.
The Latest on: Arthritis
via Google News
The Latest on: Arthritis
- Roche Sending Arthritis Drug to Coronavirus Doctorson March 24, 2020 at 10:53 am
La Maison Bleue" Episode #1.9 (TV Episode) on IMDb: Movies, TV, Celebs, and ...
- Psoriatic Arthritis Therapeutics Market Size, Historical Growth, Analysis, Opportunities and Forecast To 2026on March 24, 2020 at 7:23 am
The ‘ Psoriatic Arthritis Therapeutics market’ study now available at MarketStudyReport.com, is a detailed sketch of ...
- Roche Tests Arthritis Drug Actemra For COVID-19 Pneumoniaon March 24, 2020 at 2:43 am
The anti-inflammatory drug could help patients infected with the novel coronavirus.
- Everything Tatum O'Neal Has Said About Her Rheumatoid Arthritison March 23, 2020 at 5:08 pm
Tatum O'Neal has been open about her rheumatoid arthritis, keeping fans updated on surgeries, recoveries, struggles and successes. Take a look what the actress, 56, has said about dealing with the ...
- Psoriatic Arthritis and Your Eyes: Common Issues and How to Manage Themon March 23, 2020 at 2:59 pm
If you have psoriatic arthritis (PsA), you’re likely familiar with the joint inflammation and pain it can cause. But did you know that some people with PsA also develop inflammation of the eyes?
- Gift Guide for Psoriatic Arthritis: Ideas for Loved Ones or Self-Careon March 23, 2020 at 11:49 am
I think it’s safe to say we all love gifts that make our lives easier and less painful. If you search online for gift ideas for people with psoriatic arthritis (PsA), you’ll find the same suggestions ...
- Roche gets U.S. FDA nod for trial to test arthritis drug on coronavirus patientson March 23, 2020 at 6:51 am
Roche Holding AG said on Monday it has received the U.S. Food and Drug Administration’s clearance to test its rheumatoid arthritis treatment on patients hospitalized with severe pneumonia caused by ...
- Psoriatic Arthritis Treatment Market Value Rising with 9.9 % CAGR by 2020 to 2026on March 23, 2020 at 4:57 am
Psoriatic Arthritis Treatment market is expected to grow at noteworthy CAGR around 9.9 % throughout the forecast period and reach around US$ 17.8 billion by 2026. Acumen Research and Consulting has ...
- Malaria and arthritis drugs touted as potential coronavirus 'cure', triggering pharmacy rushon March 23, 2020 at 1:00 am
Australian pharmacies see unprecedented demand for two antimalarial medications touted as a potential treatment for COVID-19, in turn creating a shortage for patients that actually needed them.
- Arthritis drug answer to pregnancy malaria, study findson March 20, 2020 at 7:16 am
Babies exposed to malaria in the womb can suffer low birth weight and miscarriages, but a new study has found a common arthritis drug could put an end to the scourge of placental malaria. Maternal ...
via Bing News